RS49900B - Sistem za trans dermalni prenos - Google Patents
Sistem za trans dermalni prenosInfo
- Publication number
- RS49900B RS49900B YUP-226/99A YU22699A RS49900B RS 49900 B RS49900 B RS 49900B YU 22699 A YU22699 A YU 22699A RS 49900 B RS49900 B RS 49900B
- Authority
- RS
- Serbia
- Prior art keywords
- copolymer
- polymer
- hydrophilic
- hydrophobic
- copolymers
- Prior art date
Links
- 229920001577 copolymer Polymers 0.000 abstract 6
- 229920001477 hydrophilic polymer Polymers 0.000 abstract 4
- 229920001600 hydrophobic polymer Polymers 0.000 abstract 4
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 abstract 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 abstract 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 abstract 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 2
- YHHHHJCAVQSFMJ-FNORWQNLSA-N (3e)-deca-1,3-diene Chemical compound CCCCCC\C=C\C=C YHHHHJCAVQSFMJ-FNORWQNLSA-N 0.000 abstract 1
- CKGQJOFAVYEVFG-KXQOOQHDSA-N 2-fluoro-4-[[(1R)-6-[2-[4-[1-(4-methoxyphenyl)-5-methyl-6-oxopyridazin-3-yl]triazol-1-yl]ethoxy]-1-methyl-1-[2-oxo-2-(1,3-thiazol-2-ylamino)ethyl]-3,4-dihydro-2H-isoquinolin-7-yl]oxy]benzoic acid Chemical compound COc1ccc(cc1)-n1nc(cc(C)c1=O)-c1cn(CCOc2cc3CCN[C@](C)(CC(=O)Nc4nccs4)c3cc2Oc2ccc(C(O)=O)c(F)c2)nn1 CKGQJOFAVYEVFG-KXQOOQHDSA-N 0.000 abstract 1
- ZKYCLDTVJCJYIB-UHFFFAOYSA-N 2-methylidenedecanamide Chemical compound CCCCCCCCC(=C)C(N)=O ZKYCLDTVJCJYIB-UHFFFAOYSA-N 0.000 abstract 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 abstract 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical group CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 abstract 1
- 229920001800 Shellac Polymers 0.000 abstract 1
- 229920002125 Sokalan® Polymers 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 125000005250 alkyl acrylate group Chemical group 0.000 abstract 1
- 229920003144 amino alkyl methacrylate copolymer Polymers 0.000 abstract 1
- 229960001631 carbomer Drugs 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229920006037 cross link polymer Polymers 0.000 abstract 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 abstract 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 abstract 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 abstract 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
- 229940113147 shellac Drugs 0.000 abstract 1
- 239000004208 shellac Substances 0.000 abstract 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 abstract 1
- 235000013874 shellac Nutrition 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Virology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
1. Tečni preparat za transdermalni prenos jednog ili više fizioloških agenasa, naznačen time, što sadrži barem jedan fiziološki aktivni agens, isparljiv rastvarač, hidrofilni polimer i hidrofobni polimer koji se sastoji od: i) hidrofilnog polimera izabranog iz grupe koju čine hidroksipropilmetil celuloza, hidroksipropil celuloza, polivinil pirolidon, karbomer, PVM/MA dekadien kros polimer i hidroksipropilguar i njihovi kopolimeri, ii) hidrofobnog polimera izabranog iz grupe koju čine oktilakrilamid akrilat kopolimer, aminoalkil metakrilat kopolier, amonio metakrilat kopolimer, kopolimer PVP/VA, PVA, PVM/MA butilestar kopolimer, šelak, alkil akrilat i njegovi kopolimeri, gde je kombinacija hidrofilnih i hidrofobnih polimera izabrana da obezbedi modulaciju brzine prenosa pomenutog fiziološki aktivnog sastojka, uz uslov da kada je hidrofilni polimer hidroksipropilceluloza, hidrofobni polimer nije etilakrilat/metil matakrilat kopolimer.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPO3795A AUPO379596A0 (en) | 1996-11-22 | 1996-11-22 | Percutaneous delivery system |
Publications (2)
Publication Number | Publication Date |
---|---|
YU22699A YU22699A (sh) | 2002-06-19 |
RS49900B true RS49900B (sr) | 2008-08-07 |
Family
ID=3798105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YUP-226/99A RS49900B (sr) | 1996-11-22 | 1997-11-24 | Sistem za trans dermalni prenos |
Country Status (19)
Country | Link |
---|---|
US (1) | US6211250B1 (sr) |
EP (1) | EP0944398B1 (sr) |
JP (2) | JP4358305B2 (sr) |
KR (1) | KR100551930B1 (sr) |
AT (1) | ATE263577T1 (sr) |
AU (2) | AUPO379596A0 (sr) |
CA (1) | CA2271139C (sr) |
CZ (1) | CZ289152B6 (sr) |
DE (1) | DE69728556T2 (sr) |
DK (1) | DK0944398T3 (sr) |
ES (1) | ES2219758T3 (sr) |
HU (1) | HU225586B1 (sr) |
NO (1) | NO322899B1 (sr) |
PL (1) | PL191824B1 (sr) |
PT (1) | PT944398E (sr) |
RS (1) | RS49900B (sr) |
SK (1) | SK284135B6 (sr) |
WO (1) | WO1998023291A1 (sr) |
ZA (1) | ZA9710560B (sr) |
Families Citing this family (126)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9504265D0 (en) * | 1995-03-03 | 1995-04-19 | Medeva Plc | Corticosteroid-containing pharmaceutical composition |
AUPN814496A0 (en) * | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
AUPO983897A0 (en) * | 1997-10-17 | 1997-11-06 | Soltec Research Pty Ltd | Topical antifungal composition |
AUPP310798A0 (en) | 1998-04-22 | 1998-05-14 | Soltec Research Pty Ltd | Vehicle system for a composition comprising a piperidinopyrimidine derivative |
MXPA01001752A (es) * | 1998-08-20 | 2002-04-08 | 3M Innovative Properties Co | Parche en aerosol y sistema de aplicacion de medicamento. |
US6962691B1 (en) | 1999-05-20 | 2005-11-08 | U & I Pharmaceuticals Ltd. | Topical spray compositions |
US6228354B1 (en) * | 1999-07-02 | 2001-05-08 | Allegiance Corporation | Water resistant film-forming antimicrobial skin-preparation |
US6528086B2 (en) * | 1999-09-28 | 2003-03-04 | Zars, Inc. | Methods and apparatus for drug delivery involving phase changing formulations |
US20030044432A1 (en) * | 2000-09-29 | 2003-03-06 | Manetta Vincent E. | Acne treating composition |
WO2002049620A2 (en) * | 2000-12-21 | 2002-06-27 | Inhale Therapeutic Systems, Inc. | Induced phase transition method for the production of microparticles containing hydrophobic active agents |
US6528076B2 (en) | 2001-07-06 | 2003-03-04 | Magic Herb Corp. | Topical compositions and methods for treating pain |
US8501202B2 (en) * | 2001-07-09 | 2013-08-06 | Aqua Pharmaceuticals, Llc | Sulfacetamide formulations for treatment of skin dermatoses |
US20040018237A1 (en) * | 2002-05-31 | 2004-01-29 | Perricone Nicholas V. | Topical drug delivery using phosphatidylcholine |
US8435942B2 (en) * | 2002-05-31 | 2013-05-07 | Transdermal Biotechnology, Inc. | Methods for formulating stabilized insulin compositions |
NZ537359A (en) * | 2002-06-25 | 2006-10-27 | Cosmeceutic Solutions Pty Ltd | Topical cosmetic compositions for transdermal delivery |
BRPI0312007B1 (pt) | 2002-06-25 | 2015-04-14 | Acrux Dds Pty Ltd | Composição farmacêutica para administração transcutânea de testosterona ou fentanil e uso da dita composição |
US20050186141A1 (en) * | 2002-06-25 | 2005-08-25 | Acrux Dds Pty Ltd. | Transdermal aerosol compositions |
AU2002950506A0 (en) * | 2002-07-31 | 2002-09-12 | Soltec Research Pty Ltd | Percutaneous delivery system |
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
CA2502986C (en) | 2002-10-25 | 2011-08-23 | Foamix Ltd. | Cosmetic and pharmaceutical foam |
US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
NZ541526A (en) * | 2003-01-24 | 2008-03-28 | Stiefel Res Australia Pty Ltd | Clindamycin phosphate foam |
US7871818B2 (en) * | 2003-01-31 | 2011-01-18 | Roche Madison Inc. | Membrane active polymers |
US7186416B2 (en) | 2003-05-28 | 2007-03-06 | Stiefel Laboratories, Inc. | Foamable pharmaceutical compositions and methods for treating a disorder |
EP1498133A1 (en) | 2003-07-18 | 2005-01-19 | Aventis Pharma Deutschland GmbH | Use of a pak inhibitor for the treatment of a joint disease |
US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
EP1531333A1 (en) | 2003-11-12 | 2005-05-18 | Aventis Pharma Deutschland GmbH | Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-lle347 polymorphism |
DE102004019916A1 (de) * | 2004-04-21 | 2005-11-17 | Grünenthal GmbH | Gegen Missbrauch gesichertes wirkstoffhaltiges Pflaster |
ES2442386T3 (es) | 2004-04-23 | 2014-02-11 | Bundesrepublik Deutschland Letztvertreten Durch Das Robert Koch-Institut Vertreten Durch Seinen Pr | Método para el tratamiento de condiciones mediadas por células T por la disminución de las células positivas de ICOS in vivo. |
US20070196452A1 (en) * | 2004-06-07 | 2007-08-23 | Jie Zhang | Flux-enabling compositions and methods for dermal delivery of drugs |
US20070196293A1 (en) * | 2004-06-07 | 2007-08-23 | Jie Zhang | Compositions and methods for treating photo damaged skin |
US20070196457A1 (en) * | 2004-06-07 | 2007-08-23 | Jie Zhang | Two or more volatile solvent-containing compositions and methods for dermal delivery of drugs |
US20070190124A1 (en) * | 2004-06-07 | 2007-08-16 | Jie Zhang | Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs |
US8741333B2 (en) | 2004-06-07 | 2014-06-03 | Nuvo Research Inc. | Compositions and methods for treating dermatitis or psoriasis |
US20070196323A1 (en) * | 2004-06-07 | 2007-08-23 | Jie Zhang | Polyvinyl alcohol-containing compositions and methods for dermal delivery of drugs |
US20070196453A1 (en) * | 2004-06-07 | 2007-08-23 | Jie Zhang | Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs |
US20070196325A1 (en) * | 2004-06-07 | 2007-08-23 | Jie Zhang | Compositions and methods for dermally treating infections |
US8741332B2 (en) * | 2004-06-07 | 2014-06-03 | Nuvo Research Inc. | Compositions and methods for dermally treating neuropathic pain |
US20080019927A1 (en) * | 2004-06-07 | 2008-01-24 | Jie Zhang | Compositions and methods for dermally treating neuropathy with minoxidil |
US20070189978A1 (en) * | 2004-06-07 | 2007-08-16 | Jie Zhang | Compositions and methods for dermally treating musculoskeletal pain |
US8907153B2 (en) * | 2004-06-07 | 2014-12-09 | Nuvo Research Inc. | Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same |
US20080132580A1 (en) * | 2004-12-17 | 2008-06-05 | Mandavilli Sarveswara Rao Srir | Dispersion For Delivering Active Agents |
EP1861711B1 (en) | 2005-03-11 | 2012-01-11 | Sanofi | Use of mgc4504 |
BRPI0611134A2 (pt) * | 2005-06-03 | 2010-08-17 | Acrux Dds Pty Ltd | método e composição para liberação transdérmica de fármaco |
AU2006254742C1 (en) * | 2005-06-03 | 2011-11-03 | Acrux Dds Pty Ltd | Method and composition for transdermal drug delivery |
US8053000B2 (en) | 2005-06-07 | 2011-11-08 | Dr. Reddy's Laboratories Limited | Compositions for drug delivery |
US20090214443A1 (en) * | 2005-07-28 | 2009-08-27 | Thomas Chan | Method for retarding systemic delivery rate for easily absorbable active agents |
RU2417073C2 (ru) | 2005-09-29 | 2011-04-27 | Новартис Аг | Противогрибковая композиция |
CN101262848B (zh) * | 2005-09-29 | 2011-05-11 | 诺瓦提斯公司 | 抗真菌组合物 |
DE102005048898A1 (de) | 2005-10-12 | 2007-04-19 | Sanofi-Aventis Deutschland Gmbh | EGLN2-Varianten und ihre Verwendung bei der Vorbeugung oder Behandlung thromboembolischer Erkrankungen und koronarer Herzerkrankungen |
EP1795609A1 (en) | 2005-12-06 | 2007-06-13 | Sanofi-Aventis Deutschland GmbH | Method for the diagnosis and treatment of cardiovascular diseases |
KR101368107B1 (ko) | 2006-03-31 | 2014-03-14 | 스티펠 리서치 오스트레일리아 피티와이 리미티드 | 발포성 현탁겔 |
US20070280972A1 (en) * | 2006-04-25 | 2007-12-06 | Zars, Inc. | Adhesive solid gel-forming formulations for dermal drug delivery |
JP5432716B2 (ja) | 2006-10-17 | 2014-03-05 | ヌーボ リサーチ インコーポレイテッド | ジクロフェナクゲル |
DE102006049929B4 (de) * | 2006-10-19 | 2012-03-08 | Beiersdorf Ag | Filmbildende Gelkomposition zur Wund- bzw. Hautpflege |
US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
JP2010511723A (ja) * | 2006-12-04 | 2010-04-15 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | 局所医薬組成物 |
BRPI0720945A2 (pt) | 2007-01-11 | 2012-12-25 | Acrux Dds Pty Ltd | instrumento espalhador |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
ES2671874T3 (es) | 2007-10-18 | 2018-06-11 | Rose U, Llc | Formulaciones tópicas de glicopirrolato |
WO2009069006A2 (en) | 2007-11-30 | 2009-06-04 | Foamix Ltd. | Foam containing benzoyl peroxide |
WO2009090495A2 (en) | 2007-12-07 | 2009-07-23 | Foamix Ltd. | Oil and liquid silicone foamable carriers and formulations |
EP2105742A1 (en) | 2008-03-26 | 2009-09-30 | Sanofi-Aventis | Use of cathepsin C |
DK2310003T3 (da) | 2008-06-27 | 2020-05-18 | Cptone Biotech Aps | Inhibitorer af Carnitin-Palmitoyl-Transferase-1 til behandling og forebyggelse af lidelser forårsaget af delipidering af neuralt væv |
AU2009290915B2 (en) * | 2008-09-10 | 2014-09-11 | Novartis Ag | Compositions for percutaneous administration |
US9012477B2 (en) * | 2009-01-06 | 2015-04-21 | Nuvo Research Inc. | Method of treating neuropathic pain |
US8618164B2 (en) | 2009-03-31 | 2013-12-31 | Nuvo Research Inc. | Treatment of pain with topical diclofenac compounds |
CA2760186C (en) | 2009-04-28 | 2019-10-29 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
CA2769677A1 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
EP2293072A1 (en) | 2009-08-31 | 2011-03-09 | Sanofi-Aventis | Use of cathepsin H |
CA2776366C (en) | 2009-10-02 | 2017-07-18 | Foamix Ltd. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
EP2523660A4 (en) | 2010-01-14 | 2013-07-10 | Nuvo Res Inc | FORMATION OF SOLID FORMS OF LOCAL ANESTHESIA FORMULATIONS FOR FIGHTING PAIN |
EP2444067A1 (en) | 2010-10-20 | 2012-04-25 | Laboratorios Ojer Pharma S.L. | Anhydrous gel comprising mupirocin |
CA2719512A1 (en) | 2010-11-01 | 2012-05-01 | Stiefel Research Australia Pty Ltd | Polymeric topical compositions |
TW201238974A (en) | 2010-12-17 | 2012-10-01 | Sanofi Sa | MiRNAs in joint disease |
TW201241179A (en) | 2010-12-17 | 2012-10-16 | Sanofi Sa | MiRNAs in joint disease |
TW201239097A (en) | 2010-12-17 | 2012-10-01 | Sanofi Sa | MiRNAs in joint disease |
TW201238973A (en) | 2010-12-17 | 2012-10-01 | Sanofi Sa | MiRNAs in joint disease |
JP2014508166A (ja) | 2011-03-17 | 2014-04-03 | トランスダーマル バイオテクノロジ インコーポレーテッド | 局所的一酸化窒素システム及びその使用方法 |
KR20140027319A (ko) * | 2011-05-26 | 2014-03-06 | 노파르티스 아게 | 생리학상 활성제의 경피 투여를 위한 조성물 |
US8871259B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Techniques and systems for treatment of neuropathic pain and other indications |
US8871254B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system |
US8871258B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Treatment and prevention of learning and memory disorders |
US8871261B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Cancer treatments and compositions for use thereof |
US8871256B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Methods and systems for treatment of inflammatory diseases with nitric oxide |
US8871255B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Treatment of skin and soft tissue infection with nitric oxide |
US8871257B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery |
US8871262B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Compositions and methods for treatment of osteoporosis and other indications |
US8871260B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Methods and compositions for muscular and neuromuscular diseases |
KR101457789B1 (ko) | 2013-02-13 | 2014-11-03 | 동아제약 주식회사 | 상처 치료용 필름형성 약제학적 조성물 및 그의 제조방법 |
US9295637B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Compositions and methods for affecting mood states |
US9393265B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
US9314433B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
US20140271938A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
US9387159B2 (en) | 2013-03-13 | 2016-07-12 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
US9295647B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
US9320706B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
US9295636B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
US9687520B2 (en) | 2013-03-13 | 2017-06-27 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
US20140271731A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
US9339457B2 (en) | 2013-03-13 | 2016-05-17 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
US9750787B2 (en) | 2013-03-13 | 2017-09-05 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
US9314423B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Hair treatment systems and methods using peptides and other compositions |
US9241899B2 (en) | 2013-03-13 | 2016-01-26 | Transdermal Biotechnology, Inc. | Topical systems and methods for treating sexual dysfunction |
US9314422B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
US9849160B2 (en) | 2013-03-13 | 2017-12-26 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
US9393264B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
US9314417B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
US20140271937A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
US9320758B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
US9724419B2 (en) | 2013-03-13 | 2017-08-08 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
USD749225S1 (en) | 2013-11-26 | 2016-02-09 | Acrux Dds Pty Ltd | Topical spreading applicator |
USD750788S1 (en) | 2013-11-26 | 2016-03-01 | Acrux Dds Pty Ltd | Topical spreading applicator |
TW201629140A (zh) | 2015-02-09 | 2016-08-16 | Genepharm Biotech Corp | 可成膜的凝膠組成物 |
KR101580077B1 (ko) | 2015-03-28 | 2015-12-24 | 한국콜마주식회사 | 시크로피록스 함유 네일락카 조성물 |
MX2017011630A (es) | 2016-09-08 | 2018-09-25 | Foamix Pharmaceuticals Ltd | Composiciones y metodos para tratar rosacea y acne. |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4675009A (en) * | 1977-11-07 | 1987-06-23 | Lec Tec Corporation | Drug dispensing device for transdermal delivery of medicaments |
GB2075837B (en) | 1980-05-14 | 1984-03-14 | Hisamitsu Pharmaceutical Co | Topical pharmaceutical gel containing anti-inflammatory analgesic agents |
US4713244A (en) * | 1985-08-16 | 1987-12-15 | Bausch & Lomb Incorporated | Sustained-release formulation containing an amino acid polymer with a lower alkyl (C1 -C4) polar solvent |
DE3868248D1 (de) * | 1987-05-27 | 1992-03-12 | Burghart Kurt | Transdermal therapeutisch wirkende pharmazeutische zubereitung sowie vorrichtung zum aufbringen der zubereitung. |
US4954332A (en) | 1987-10-22 | 1990-09-04 | The Procter & Gamble Company | Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent |
JPH0818983B2 (ja) * | 1987-12-08 | 1996-02-28 | 塩野義製薬株式会社 | 水虫治療剤 |
EP0319988A1 (en) * | 1987-12-09 | 1989-06-14 | Showa Denko Kabushiki Kaisha | External dermatological composition |
US5081157A (en) | 1988-05-02 | 1992-01-14 | Zila Pharmaceuticals, Inc. | Compositions and in situ methods for forming films on body tissue |
US4940579A (en) * | 1988-12-27 | 1990-07-10 | Minnesota Mining And Manufacturing Company | Topical application of medicament in a binder |
US5674912A (en) | 1991-03-01 | 1997-10-07 | Warner-Lambert Company | Sunscreen-wound healing compositions and methods for preparing and using same |
AU658681B2 (en) * | 1991-10-23 | 1995-04-27 | Block Drug Company Inc., The | Penetration enhancement of topically applied formulations |
AU3073792A (en) | 1991-11-25 | 1993-06-28 | Richardson-Vicks Inc. | Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
IL105748A0 (en) * | 1992-05-22 | 1993-09-22 | Int Research & Dev Corp | Topical antiperspirant composition |
US5304368A (en) * | 1993-02-19 | 1994-04-19 | American Telecast Corporation | Non-foaming, non-viscous, alcohol-free, water-based, pressurized hair spray product |
US5436241A (en) | 1994-01-14 | 1995-07-25 | Bristol-Myers Squibb Company | Topical anti-inflammatory compositions containing piroxicam |
CA2188566A1 (en) * | 1994-05-05 | 1995-11-16 | Conrad Winters | Topical polymeric drug delivery system |
FR2732223B1 (fr) * | 1995-03-30 | 1997-06-13 | Sanofi Sa | Composition pharmaceutique pour administration transdermique |
-
1996
- 1996-11-22 AU AUPO3795A patent/AUPO379596A0/en not_active Abandoned
-
1997
- 1997-11-24 SK SK645-99A patent/SK284135B6/sk not_active IP Right Cessation
- 1997-11-24 PT PT97911978T patent/PT944398E/pt unknown
- 1997-11-24 KR KR1019997004447A patent/KR100551930B1/ko not_active IP Right Cessation
- 1997-11-24 EP EP97911978A patent/EP0944398B1/en not_active Expired - Lifetime
- 1997-11-24 AT AT97911978T patent/ATE263577T1/de not_active IP Right Cessation
- 1997-11-24 DK DK97911978T patent/DK0944398T3/da active
- 1997-11-24 CZ CZ19991812A patent/CZ289152B6/cs not_active IP Right Cessation
- 1997-11-24 AU AU49367/97A patent/AU723143C/en not_active Expired
- 1997-11-24 JP JP52405398A patent/JP4358305B2/ja not_active Expired - Lifetime
- 1997-11-24 WO PCT/AU1997/000797 patent/WO1998023291A1/en not_active Application Discontinuation
- 1997-11-24 CA CA002271139A patent/CA2271139C/en not_active Expired - Lifetime
- 1997-11-24 ZA ZA9710560A patent/ZA9710560B/xx unknown
- 1997-11-24 ES ES97911978T patent/ES2219758T3/es not_active Expired - Lifetime
- 1997-11-24 US US09/308,574 patent/US6211250B1/en not_active Expired - Lifetime
- 1997-11-24 DE DE69728556T patent/DE69728556T2/de not_active Expired - Lifetime
- 1997-11-24 RS YUP-226/99A patent/RS49900B/sr unknown
- 1997-11-24 PL PL333587A patent/PL191824B1/pl unknown
- 1997-11-24 HU HU9903792A patent/HU225586B1/hu unknown
-
1999
- 1999-05-11 NO NO19992290A patent/NO322899B1/no not_active IP Right Cessation
-
2008
- 2008-04-16 JP JP2008107196A patent/JP2008247912A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS49900B (sr) | Sistem za trans dermalni prenos | |
KR950005301A (ko) | 방출 개시 제어 및 방출 속도 제어형 제제 | |
JP3537900B2 (ja) | ポリビニルピロリドンとキトサンとの相互作用で形成されるゲル | |
CA2214100A1 (en) | Sustained release formulation containing three different types of polymers | |
AU1702395A (en) | Drugs, vaccines and hormones in polylactide coated microspheres | |
US8343473B2 (en) | Hydrophilized antimicrobial polymers | |
ATE319421T1 (de) | Lokale arzneistoffabgabe | |
US8128946B2 (en) | Medical tape preparation | |
CA2214845A1 (fr) | Composition pharmaceutique filmogene pour administration transdermique | |
TW336173B (en) | Pharmaceutical composition for healing damaged skin | |
UA94917C2 (ru) | Композиции для местного применения | |
RU2009117711A (ru) | Фармацевтические твердые дозированные формы, содержащие соединения, микровключенные в ионогенные не растворимые в воде полимеры | |
EP0848960A3 (de) | Haft- und Bindemittel für dermale oder transdermale Therapiesysteme | |
ATE264348T1 (de) | Bioadhesive zusammensetzungen aus polymeren | |
WO1998022097A3 (en) | Controlled release matrix composition using polar polymer or monomer and poly(acrylic acid) blend | |
RU2005122439A (ru) | Композиция, включающая фенофибриновую кислоту, ее физиологически приемлемую соль или производное | |
US7378085B2 (en) | Long-retention hairstyling gel | |
JPS63264687A (ja) | 塩基性の活性成分透過性の触圧接着性ポリマー材料及びその製造方法 | |
AU2002363885A1 (en) | Adhesive and binding agent for dermal or transdermal treatment systems | |
CZ386797A3 (cs) | Přípravek k prevenci a hojení zánětlivých onemocnění | |
WO2002060417A8 (de) | Lagerstabiles haft- und bindemittel für pharmazeutische anwendungen | |
MXPA04006256A (es) | Formulaciones transdermicas adhesivas de diclofenac sodico. | |
EP1179337A2 (en) | Use of polymers as film-forming barrier materials | |
NO954879L (no) | Papirbestrykingsmasser som inneholder et emulsjonskopolymerisat som bindemiddel | |
PL328043A1 (en) | Thickening agent of the basis of polymers containing carboxyl end carboxyloamide drug |